Cargando…
Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Amiodarone has emerged as the leading antiarrhythmic therapy for termination and prevention of ventricular arrhythmia in different clinical settings because of its proven efficacy and safety. In patients with shock refractory out-of-hospital cardiac arrest and hemodynamically destabilizing ventricul...
Autores principales: | Van Herendael, Hugo, Dorian, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2922307/ https://www.ncbi.nlm.nih.gov/pubmed/20730062 |
Ejemplares similares
-
Meta-analysis of the efficacies of amiodarone and nifekalant in shock-resistant ventricular fibrillation and pulseless ventricular tachycardia
por: Sato, Shiho, et al.
Publicado: (2017) -
Impact of Amiodarone Therapy on the Ablation Outcome of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy
por: Lin, Chin-Yu, et al.
Publicado: (2022) -
Promising Therapies for Atrial Fibrillation and Ventricular Tachycardia
por: Mircea, Andrei Alexandru, et al.
Publicado: (2022) -
Dopamine in Idiopathic Polymorphic Ventricular Tachycardia/Ventricular Fibrillation
por: Rabah, Hussein, et al.
Publicado: (2021) -
Amiodarone versus lidocaine for the prevention of reperfusion ventricular fibrillation: A randomized clinical trial
por: Alizadeh-Ghavidel, Alireza, et al.
Publicado: (2013)